Reference page — cumulative record through Sunday, October 4, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Rclone
Product reference — Rclone by Rclone · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 29 | 29 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 6.9 | .0030 | 4 | 8 | 15 | 2 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▂▃█▇▁
| Month | New CVEs |
|---|---|
| 2026-06 | 1 |
| 2026-07 | 3 |
| 2026-08 | 14 |
| 2026-09 | 11 |
| 2026-10 | 0 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-49980 | 9.8 | 54.4 | CRITICAL | — | 2026-06-24 |
| CVE-2026-88045 | 7.5 | 48.4 | HIGH | — | 2026-09-10 |
| CVE-2026-71310 | 5.9 | 47.4 | MEDIUM | — | 2026-08-05 |
| CVE-2026-59733 | 8.8 | 44.2 | HIGH | — | 2026-07-14 |
| CVE-2026-88018 | 9.8 | 41.5 | CRITICAL | — | 2026-09-10 |
| CVE-2026-88044 | 9.1 | 40.1 | CRITICAL | — | 2026-09-10 |
| CVE-2026-71312 | 8.0 | 40.0 | HIGH | — | 2026-08-05 |
| CVE-2026-71309 | 8.6 | 37.6 | HIGH | — | 2026-08-05 |
| CVE-2026-54572 | 8.8 | 32.4 | HIGH | — | 2026-07-14 |
| CVE-2026-71311 | 6.4 | 30.9 | MEDIUM | — | 2026-08-05 |
| CVE-2026-79776 | 6.9 | 29.7 | MEDIUM | — | 2026-08-25 |
| CVE-2026-79775 | 7.1 | 28.7 | HIGH | — | 2026-08-25 |
| CVE-2026-88015 | 5.3 | 27.4 | MEDIUM | — | 2026-09-10 |
| CVE-2026-79781 | 6.9 | 20.9 | MEDIUM | — | 2026-08-25 |
| CVE-2026-79777 | 5.1 | 20.5 | MEDIUM | — | 2026-08-25 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-93987 | 4.6 | 3.6 | MEDIUM | — | 2026-09-19 |
| CVE-2026-93986 | 2.3 | 19.4 | LOW | — | 2026-09-19 |
| CVE-2026-88016 | 7.1 | 7.5 | HIGH | — | 2026-09-10 |
| CVE-2026-88046 | 5.3 | 20.0 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88017 | 7.3 | 13.0 | HIGH | — | 2026-09-10 |
| CVE-2026-88015 | 5.3 | 27.4 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88018 | 9.8 | 41.5 | CRITICAL | — | 2026-09-10 |
| CVE-2026-88014 | 6.3 | 3.6 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88013 | 5.3 | 7.5 | MEDIUM | — | 2026-09-10 |
| CVE-2026-88044 | 9.1 | 40.1 | CRITICAL | — | 2026-09-10 |
| CVE-2026-88045 | 7.5 | 48.4 | HIGH | — | 2026-09-10 |
| CVE-2026-79775 | 7.1 | 28.7 | HIGH | — | 2026-08-25 |
| CVE-2026-79782 | 9.3 | 2.3 | CRITICAL | — | 2026-08-25 |
| CVE-2026-79777 | 5.1 | 20.5 | MEDIUM | — | 2026-08-25 |
| CVE-2026-79779 | 6.0 | 1.1 | MEDIUM | — | 2026-08-25 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Rclone — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
